Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion

Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.

We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Every outlet that reported this, and when →

Read the original at bloomberg.com →

More in Health & Medicine

Japan Begins Talks on Free Childbirth

Japan has begun detailed discussions on a new system to make childbirth free of charge, with the government aiming to introduce nationwide coverage by June 2028 and the establishment of a uniform…

More from Friday 2 October →